Dextromethorphan and guaifenesin use must be monitored cautiously in patients with "weak metabolizer" CYP2D6 enzyme degrees and individuals that are sedated. This mix medication includes a significant median poisonous dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these patients. Often times this drug is taken on https://philm542tgs6.wikilima.com/user